Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma - Concepedia

Concepedia

Publication | Open Access

Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma

DOI Full Paper Access

793

Citations

31

References

2010

Year

John H. Sampson, Amy B. Heimberger, Gary E. Archer, Kenneth Aldape, Allan H. Friedman, Henry S. Friedman, Mark R. Gilbert, James E. Herndon, Roger E. McLendon, Duane A. Mitchell,

Journal of Clinical Oncology

Abstract

EGFRvIII-targeted vaccination in patients with GBM warrants investigation in a phase III, randomized trial.

References

	Year	Citations

Page 1